A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities

Acta Obstetricia et Gynecologica Scandinavica

Volumn 84, Issue 10, 2005, Pages 996-1000

  Andersson, Sonia ^a   Dillner, Lena ^b   Elfgren, Kristina ^a   Mints, Miriam ^a   Persson, Maria ^c   Rylander, Eva ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

CIN; HPV; Pap smear; Screening

Indexed keywords

ADULT; ARTICLE; COLPOSCOPY; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SWEDEN; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 25844441585     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2005.00702.x     Document Type: Article

References (26)

1. Mählck CG, Jonsson H, Lenner P. Pap smear screening and changes in cervical cancer mortality in Sweden. Int J Gynaecol Obstet 1994; 44: 267-72.
2. Ponten J, Adami HO, Friberg LG, Gustafsson L, Miller AB, Parkin M et al. HPV and cervical cancer. Int J Cancer 1995; 63: 317.
3. Ferris DG, Wright TC Jr, Litaker MS, Richart RM, Lorincz AT, Sun XW et al. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy? J Fam Pract 1998; 46: 125-34.
4. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995; 172: 946-54.
5. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ et al. Identifying women with cervical neoplasia. Using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999; 218: 1605-10.
6. Flannelly G, Anderson D, Kitchener HC, Mann EM, Campbell M, Fisher P et al. Management of women with mild and moderate cervical dyskaryosis. BMJ 1994; 308: 1399-403.
7. Solomon D, Schiffman M, Tarone R. ASCUS LSIL Triage Study (ALTS) conclusions reaffirmed: response to a November 2001 commentary. Obstet Gynecol 2002; 99: 671-4.
8. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman M. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA 1994; 271: 1866-9.
9. Austoker J. Cancer prevention in primary care. Screening for cervical cancer. BMJ 1994; 309: 241-8.
10. Freeman-Wang T, Walker P, Linehan J, Coffey C, Glasser B, Sherr L. Anxiety levels in women attending colposcopy clinics for treatment for cervical intraepithelial neoplasia: a randomised trial of written and video information. BJOG 2001; 108: 482-4.
11. Idestrom M, Milsom I, Andersson-Ellstrom A. Women's experience of coping with a positive Pap smear: a register-based study of women with two consecutive Pap smears reported as CIN 1. Acta Obstet Gynecol Scand 2003; 82: 756-61.
12. Elfgren K, Kalantari M, Moberger B, Hagmar B, Dillner J. A population-based five-year follow-up study of cervical human papillomavirus infection. Am J Obstet Gynecol 2000; 183: 561-7.
13. Schiffman M, Brinton L. The epidemiology of cervical carcinogenesis. Cancer Epidemiol Biomarkers Prev 1995; 76: 1888-901.
14. Nobbenhuis MA, Walboomers JM, Heimerhorst TJ, Rozendaal L, Remmink AJ, Risse EK et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999; 354: 20-5.
15. Schiffman MH, Castle P. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 2003; 95: E2.
16. Peyton CL, Schiffman M, Lorincz AT, Hunt WC, Mielzynska I, Bratti C et al. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 1998; 36: 3248-54.
17. Schiffman M, Harrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S et al. HPV DNA testing in cervical cancer screening: results from women in high-risk province of Costa Rica. JAMA 2000; 283: 87-93.
18. Macgregor JE, Campbell MK, Mann EM, Swanson KY. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. BMJ 1994; 308: 1407-11.
19. Sherman ME, Shiffman MH, Lorincz AT. Toward objective quality assurance in cervical cytopathology: correlation of cytopathologic diagnosis with detection of high-risk human papillomavirus types. Am J Clin Pathol 1994; 102: 182-7.
20. Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 1998; 91: 973-6.
21. Soutter WP, Fletcher A. Invasive cancer of the cervix in women with mild dyskaryosis followed up cytologically. BMJ 1994; 308: 1421-3.
22. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 9-12.
23. Schiffman M, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-64.
24. Davidson M, Schnitzer PG, Bulkow LR, Parkinson AJ, Schloss ML, Fitzgerald MA et al. The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska Native women. J Infect Dis 1994; 169: 792-800.
25. Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 2000; 163: 513-8.
26. Forslund O, Antonsson A, Edlund K, van den Brule AJ, Hansson BG, Meijer CJ et al. Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women. J Med Virol 2002; 66: 535-41.